Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,333 recruiting studies in this area right now.
By phase
- Not applicable4,394
- Phase 2610
- Phase 1412
- Phase 3321
- Phase 4272
- Phase 1/Phase 2254
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer338
- Cervical Cancer232
- Endometrial Cancer207
- Bladder Cancer189
- Acute Kidney Injury139
- Endometriosis134
- Chronic Kidney Diseases131
- Pregnancy131
- Breast Cancer108
- Chronic Kidney Disease106
- Infertility94
- Renal Cell Carcinoma81
- Colorectal Cancer74
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Pregnancy Complications64
- Urinary Incontinence63
Leading sponsors
- Mayo Clinic59
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS48
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- Assistance Publique - Hôpitaux de Paris46
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)41
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- University of Aarhus36
- AstraZeneca35
Where studies are running
- California346
- Alabama155
- Texas121
- Massachusetts119
- New York117
- Florida103
- Arizona100
- Colorado90
- Maryland89
- Illinois78
Recruiting studies6,333 total
- NCT07404969Recruiting
Integrative medicine for unexplained infertility after treatment
This trial studies whether combining traditional Chinese medicine with standard care can help women with unexplained infertility after previous treatments. It looks at aging markers in your blood to see if they affect your chances of getting pregnant.
NeuchâtelAges 25–42 - NCT07405086RecruitingPhase 4
Morning vs. afternoon immunotherapy for advanced solid tumors
This trial compares giving immunotherapy in the morning versus the afternoon to see if timing affects how well it works. It is for people with certain types of advanced or metastatic solid tumors who have not had this treatment before.
Portland, OregonAges 18 years+ - NCT07405216RecruitingPhase 4
SGLT2 inhibitors for teens with early kidney disease
This trial tests whether a type of medicine called SGLT2 inhibitors can help teenagers with early-stage chronic kidney disease. It looks at how safe and effective these drugs are for slowing down kidney damage.
Aguascalientes, AguascalientesAges 14–18 - NCT07407647RecruitingPhase 2
Vaginal DHEA for better vaginal health after pelvic radiation
This study tests whether a vaginal insert of DHEA (a hormone) can help with vaginal health problems caused by pelvic radiation for anal, rectal, or gynecologic cancers. It is for women who are already postmenopausal and are about to start radiation.
Columbus, OhioAges 50 years+ - NCT07407959Recruiting
Screening pelvic MRI for cancer or endometriosis
This study uses MRI imaging to look at pelvic masses and help tell the difference between benign (non-cancerous) and malignant (cancerous) conditions. It is designed for people referred for a prostate MRI or for endometriosis evaluation before surgery.
Rochester, MinnesotaAges 18 years+ - NCT07410494RecruitingPhase 1/Phase 2
Personalized donor cell therapy for advanced solid tumors
This trial tests a personalized cell therapy (CAR-NK) using donor immune cells that are engineered to find and attack one or two markers on advanced solid tumors. It may be an option for people whose tumors have these specific markers and have exhausted other treatments.
Beijing, Beijing MunicipalityAges 8–85 - NCT07410676RecruitingPhase 1/Phase 2
Donor NK cells with IL-15 and pembrolizumab for advanced solid tumors
This trial tests a new type of cell therapy (natural killer cells) made from a donor, combined with low-dose IL-15 (a protein that helps these cells work) and sometimes with pembrolizumab (Keytruda), for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this combination can shrink tumors or slow their growth.
Beijing, Beijing MunicipalityAges Any age - NCT07410858Recruiting
Virtual reality education for NICU parents
This study tests whether a virtual reality program can help parents learn about their baby's care in the NICU. If you join, you would use a VR headset to learn while your baby is in the hospital.
Ismailia, Ismailia, Egypt.Ages 18 years+ - NCT07411391Recruiting
Robot-assisted kidney stone removal trial
This trial tests a robot-assisted telescope-guided procedure to break up kidney stones. It may be an option if you have a kidney stone smaller than about 1.6 cm and are already scheduled for a ureteroscopy (RIRS).
Hong KongAges 19 years+ - NCT07413523Recruiting
Radiation therapy plus standard care for urothelial cancer with limited spread
This trial tests whether adding targeted radiation therapy to standard drug treatment can help people with urothelial cancer that has spread to a few spots (up to 3 outside the brain). If you are starting your first or second round of systemic therapy, this study may be an option.
Rozzano, MilanAges 18 years+ - NCT07413705Recruiting
Devices for depression and sexual health in menopause
This study tests two devices (BTL-699-2 and HPM-6000UF) to see if they can improve depression symptoms and sexual function in women going through menopause or perimenopause. It may help with mood and intimacy during this life stage.
Winter Garden, FloridaAges 40 years+ - NCT07413900Recruiting
Brain injury study for babies and toddlers
This study looks at biomarkers (biological signs) in infants who had a brain injury around birth or were born very early, and compares them with healthy babies. The goal is to learn more about brain injuries and recovery.
Madison, WisconsinAges 3 months–2 years - NCT07414511Recruiting
Hemophilia A research study for pregnant families
This study follows pregnant people who carry a severe hemophilia A gene and their babies after birth. It looks at how hemophilia A is passed down and how it affects families, with the goal of improving understanding and care.
Seattle, WashingtonAges Any age - NCT07416162Recruiting
Study of iptacopan for PNH or C3G in Korea
This trial tests a medicine called iptacopan for people with paroxysmal nocturnal hemoglobinuria (a rare blood disorder) or C3 glomerulopathy (a kidney disease). It aims to see if the drug is safe and effective for Korean patients.
JeollanamAges 18–99 - NCT07416630Recruiting
Web app for tracking radiation side effects in cancer patients
This study is testing a web-based app to help track side effects from radiation therapy in people with gynecologic, urologic, or breast cancer. If you join, you would use the app on your phone or computer to report how you're feeling, which may help your care team better manage your symptoms.
LjubljanaAges 18 years+ - NCT07416968RecruitingPhase 4
Low dose tadalafil vs solifenacin for overactive bladder in women
This study compares two medications—tadalafil (a daily pill for blood flow) and solifenacin (a pill that relaxes the bladder)—to see which works better for women with overactive bladder (OAB), which causes sudden, strong urges to urinate. It will help doctors find a treatment that may have fewer side effects.
Shibīn al Kawm, Al-MinūfiyyahAges 18–75 - NCT07417969Recruiting
Albumin with furosemide for fluid overload in ICU
This study tests whether giving a medicine called albumin together with a water pill (furosemide) helps ICU patients who have too much fluid in their body and are making very little urine. The goal is to see if this combination can improve urine output and protect kidney function.
Querétaro City, QuerétaroAges 18–100 - NCT07418242Recruiting
New markers for kidney risk after heart surgery
This study looks at whether certain blood or urine markers can predict kidney problems in people having high-risk heart surgery. The goal is to find early warning signs so doctors can take steps to protect your kidneys.
Shanghai, Shanghai MunicipalityAges 18–90 - NCT07418749RecruitingPhase 3
Testing a new drug for advanced cervical cancer after standard treatments
This trial is testing a new drug called SHR-A2102 against standard chemotherapy for people with advanced cervical cancer that has not responded to platinum-based chemotherapy and an immunotherapy (PD-1 or PD-L1 inhibitor). The goal is to see if the new drug works better and what side effects it may cause.
Guangzhou, GuangdongAges 18 years+ - NCT07420517RecruitingPhase 2
Dutasteride for low-grade bladder cancer
This trial tests if the drug dutasteride can help people with a slow-growing type of bladder cancer that hasn't spread into the muscle wall. It may be an option for those not receiving other standard treatments like BCG therapy or chemotherapy directly into the bladder.
Québec, QuebecAges 18 years+ - NCT07421908Recruiting
Study on intrauterine adhesion treatment and outcomes
This study looks at how different treatments for intrauterine adhesions (scar tissue inside the uterus) affect long-term health. It aims to find which management approach works best for patients.
Changsha, HunanAges 18–45 - NCT07422506Recruiting
Comparing treatments for early missed abortion
This study compares different treatment methods for early missed abortion (when a pregnancy ends but the tissue doesn't pass on its own) to see which works best in real-world settings. It may help you and your doctor choose the safest and most effective option.
Changsha, HunanAges 18–40 - NCT07423741Recruiting
Ultrasound study of airway measurements in pregnancy
This study uses ultrasound to measure the airway in pregnant women (with and without preeclampsia) and non-pregnant women. It helps doctors predict how easy or difficult it might be to place a breathing tube during delivery.
Qina, Qena GovernorateAges 18–50 - NCT07424547RecruitingPhase 1
Study of SYS6043 for advanced or metastatic solid tumors
This trial tests a new study drug (SYS6043) for people with advanced or metastatic solid tumors that have not responded to or are not candidates for standard therapies. The drug targets a protein called B7-H3 on cancer cells to help stop tumor growth.
Plantation, FloridaAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,333 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,314 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.